#GWAS
#Meta-analyses
#COVID-19HostGeneticsInitiative
#QCoPowerTalk
Thursday, 17 March 2022 / 10am - 11am (Malaysia Time)
The COVID-19 pandemic is a global public health issue that has ravaged multiple countries significantly. In addition, we are observing symptomatic variability across patients infected with SARS-CoV-2. Therefore, we hypothesize that the human host genetics may be important in delineating this symptomatic variability. To address this hypothesis, we facilitated a global network of researchers to investigate the role of human genetics in SARS-CoV-2 infection and COVID-19 severity.
In this talk, I will share the results of our genome-wide association meta-analyses comprised of up to 49,562 COVID-19 patients from 46 studies across 19 countries. Several of these loci correspond to previously documented associations to lung or autoimmune and inflammatory diseases. The unique speed and efficiency of this global call to arms was only made possible for the strong community of human geneticists who were eager to solve this important question with openness for sharing data, results, and analytical frameworks.